No Data
No Data
No Data
No Data
No Data
Xenon Pharmaceuticals Spotlights XEN1101 Progress
TipRanksApr 16 09:08 ET
Xenon Pharmaceuticals Announced Two Oral Presentations For XEN1101 Clinical Data At AAN 2024 Annual Meeting
Xenon's Oral Presentations at AANOral Presentation #005 (French et al.) "Interim, Long-term, Safety and Efficacy of XEN1101, a Potent, Selective Potassium Channel Opener: Update from an Ongoing Open-l
BenzingaApr 16 08:41 ET
Express News | Needham Reiterates Buy on Xenon Pharmaceuticals, Maintains $62 Price Target
Moomoo 24/7Apr 12 07:03 ET
Express News | Cantor Fitzgerald Reiterates Overweight on Xenon Pharmaceuticals, Maintains $65 Price Target
Moomoo 24/7Apr 10 09:47 ET
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the 2024 Bloom
GlobeNewswireApr 10 08:30 ET
We're Hopeful That Xenon Pharmaceuticals (NASDAQ:XENE) Will Use Its Cash Wisely
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although Amazon.com made losses for many years after l
Simply Wall StApr 7 10:41 ET
No Data
No Data